EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study

Rohith Kumar iD, Ayesha Rai, Kim Shaw, Erzsebet Santa, Francoise Cole, Hyesha McDonald, Pearl Baker, Lisa Mears, Anjan Dhar iD, Guiomar Moral-Villarejo iD, Jacobo Ortiz Fernández-Sordo iD, Ashraf Sanduka iD und 4 weitere

Alimentary Pharmacology & Therapeutics · 03.11.2026

DOI: 10.1111/apt.71080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 03.11.2026. Verfasst von Rohith Kumar und 15 weiteren Autor:innen. Beteiligte Einrichtung: East and North Hertfordshire Teaching NHS Trust, Stevenage, Herts, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Falk Pharma, Innovate UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition requiring repeat endoscopy and biopsy for histological monitoring, which is invasive, resource‐intensive and burdensome for patients. The capsule sponge (CS) offers a potential non‐invasive alternative. We evaluated the diagnostic accuracy, feasibility and patient acceptability of CS versus endoscopic biopsies for monitoring disease activity in adult patients.

Methods

A real‐world prospective multicentre cohort study was conducted across three NHS sites in England from August 2023 to June 2025. Adults with established EoE without oesophageal strictures underwent same‐day endoscopy and CS using the Endosign device. Histological activity was defined as ≥ 15 eosinophils per high‐power field or 0.3 mm 2 on endoscopic biopsy histology and CS respectively. Symptom burden was assessed using the Dysphagia Symptom Questionnaire, endoscopic severity using the EoE Endoscopic Reference Score and patient acceptability via structured questionnaire.

Results

136 patients (164 paired episodes) from three secondary care hospitals successfully swallowed CS with sufficient sampling; CS swallowing success rate was 92.7%. Median age was 45 years (IQR 34.8–56); 92/136 (67.6%) were male. CS demonstrated sensitivity 76.3%, specificity 89.5%, PPV 80.4%, NPV 87.0% and overall accuracy 84.8% (Cohen's κ = 0.67). AUC was 0.904 (95% CI 0.856–0.953). Patient acceptability recorded 96.7% found CS acceptable, 78.8% preferred it over endoscopy, and 90.8% would repeat the procedure. No complications occurred.

Conclusions

CS is a safe, feasible, accurate and highly acceptable less‐invasive tool for monitoring EoE. Its implementation could improve care pathways, reducing the need for repeated endoscopic biopsies while maintaining diagnostic reliability, with potential to reduce service burden, carbon emissions and improve patient experience. Trial Registration CoSiE: IRAS number: 314770; ClinicalTrials.gov identifier: NCT06501274; QuBiE: UK Clinical Trial registry identifier: ISRCTN14071734; Trial number: 10083253

Schlagwörter

Stichwörter der Autor:innen

capsule spongeeosinophilic oesophagitisgastroscopyhistologynon‐endoscopic monitoringpatient acceptability

Autor:innen und Institutionen

  • East and North Hertfordshire Teaching NHS Trust, Stevenage, Herts, UK.
  • County Durham & Darlington NHS Foundation Trust, Darlington, UK.
  • Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
  • Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK.
  • Cyted Ltd, Cambridge, Cambridgeshire, UK.

ORCID-Profile: Rohith Kumar, Anjan Dhar, Guiomar Moral-Villarejo, Jacobo Ortiz Fernández-Sordo, Ashraf Sanduka, Radina Georgieva, Sarah Killcoyne, Danielle L Morris

Förderung

  • Dr. Falk Pharma
  • Innovate UK

Zitieren

APA

Kumar, R., Rai, A., Shaw, K., Santa, E., Cole, F., McDonald, H., Baker, P., Mears, L., Dhar, A., Moral-Villarejo, G., Fernández-Sordo, J. O., Sanduka, A., O'Donovan, M., Georgieva, R., Killcoyne, S., & Morris, D. L. (2026). Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71080

Vancouver

Kumar R, Rai A, Shaw K, Santa E, Cole F, McDonald H, et al. Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71080

BibTeX
@article{Kumar2026,
  author = {Kumar, Rohith and Rai, Ayesha and Shaw, Kim and Santa, Erzsebet and Cole, Francoise and McDonald, Hyesha and Baker, Pearl and Mears, Lisa and Dhar, Anjan and Moral-Villarejo, Guiomar and Fernández-Sordo, Jacobo Ortiz and Sanduka, Ashraf and O'Donovan, Maria and Georgieva, Radina and Killcoyne, Sarah and Morris, Danielle L},
  title = {Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71080}
}
Kostenlos starten →